1. Schwab, M., Westermann, F., Hero, B., and Berthold, F. Neuroblastoma: biology and molecular and chromosomal pathology, Lancet Oncol. 4: 472-80., 2003. 2. Maris, J. M., Guo, C., Blake, D., White, P. S., Hogarty, M. D., Thompson, P. M., Rajalingam, V., Gerbing, R., Stram, D. O., Matthay, K. K., Seeger, R. C., and Brodeur, G. M. Comprehensive analysis of chromosome 1p deletions in neuroblastoma, Med Pediatr Oncol. 36: 32-6., 2001. 3. Spitz, R., Hero, B., Ernestus, K., and Berthold, F. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma, Clin Cancer Res. 9: 52-8., 2003. 4. Thompson, P. M., Seifried, B. A., Kyemba, S. K., Jensen, S. J., Guo, C., Maris, J. M., Brodeur, G. M., Stram, D. O., Seeger, R. C., Gerbing, R., Matthay, K. K., Matise, T. C., and White, P. S. Loss of heterozygosity for chromosome 14q in neuroblastoma, Med Pediatr Oncol. 36: 28-31., 2001. 5. Jones, P. A. and Baylin, S. B. The fundamental role of epigenetic events in cancer, Nat Rev Genet. 3: 415-28., 2002. 6. Baylin, S. B. and Herman, J. G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics, Trends Genet. 16: 168-74., 2000. 7. Dammann, R., Li, C., Yoon, J. H., Chin, P. L., Bates, S., and Pfeifer, G. P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3, Nat Genet. 25: 315-9., 2000. 8. Dammann, R., Yang, G., and Pfeifer, G. P. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers, Cancer Res. 61: 3105-9., 2001. 9. Sekido, Y., Ahmadian, M., Wistuba, II, Latif, F., Bader, S., Wei, M. H., Duh, F. M., Gazdar, A. F., Lerman, M. I., and Minna, J. D. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene, Oncogene. 16: 3151-7., 1998. 10. Agathanggelou, A., Honorio, S., Macartney, D. P., Martinez, A., Dallol, A., Rader, J., Fullwood, P., Chauhan, A., Walker, R., Shaw, J. A., Hosoe, S., Lerman, M. I., Minna, J. D., Maher, E. R., and Latif, F. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours, Oncogene. 20: 1509-18., 2001. 11. Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., Sekido, Y., Latif, F., Milchgrub, S., Toyooka, S., Gazdar, A. F., Lerman, M. I., Zabarovsky, E., White, M., and Minna, J. D. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression, J Natl Cancer Inst. 93: 691-9., 2001. 12. Kuzmin, I., Gillespie, J. W., Protopopov, A., Geil, L., Dreijerink, K., Yang, Y., Vocke, C. D., Duh, F. M., Zabarovsky, E., Minna, J. D., Rhim, J. S., Emmert-Buck, M. R., Linehan, W. M., and Lerman, M. I. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells, Cancer Res. 62: 3498-502., 2002. 13. Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zochbauer-Muller, S., Farinas, A. J., Vakar-Lopez, F., Minna, J. D., Sagalowsky, A., Czerniak, B., and Gazdar, A. F. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features, Cancer Res. 61: 8659-63., 2001. 14. Lo, K. W., Kwong, J., Hui, A. B., Chan, S. Y., To, K. F., Chan, A. S., Chow, L. S., Teo, P. M., Johnson, P. J., and Huang, D. P. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma, Cancer Res. 61: 3877-81., 2001. 15. Yoon, J. H., Dammann, R., and Pfeifer, G. P. Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas, Int J Cancer. 94: 212-7., 2001. 16. Hesson, L., Dallol, A., Minna, J. D., Maher, E. R., and Latif, F. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers, Oncogene. 22: 947-54., 2003. 17. Ortiz-Vega, S., Khokhlatchev, A., Nedwidek, M., Zhang, X. F., Dammann, R., Pfeifer, G. P., and Avruch, J. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1, Oncogene. 21: 1381-90., 2002. 18. Zabarovsky, E. R., Lerman, M. I., and Minna, J. D. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers, Oncogene. 21: 6915-35., 2002. 19 Agathanggelou, A., Dallol, A., Zochbauer-Muller, S., Morrissey, C., Honorio, S., Hesson, L., Martinsson, T., Fong, K. M., Kuo, M. J., Yuen, P. W., Maher, E. R., Minna, J. D., and Latif, F. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers, Oncogene. 22: 1580-8., 2003. 20 Teitx T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Latí JM, Kidd VJ. Caspase 8 s deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6: 529-535, 2000. 21. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc Natl Acad Sci U S A. 93: 9821-6., 1996.
|